GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 36 filers reported holding GT BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $262,132 | -23.6% | 1,087,234 | -1.1% | 0.00% | – |
| Q2 2023 | $342,999 | -44.7% | 1,099,354 | -2.5% | 0.00% | – |
| Q1 2023 | $620,073 | -37.9% | 1,127,405 | 0.0% | 0.00% | – |
| Q4 2022 | $998,543 | -49.6% | 1,127,405 | +0.0% | 0.00% | – |
| Q3 2022 | $1,983,000 | -41.1% | 1,126,941 | +0.0% | 0.00% | – |
| Q2 2022 | $3,369,000 | +18.4% | 1,126,841 | +14.1% | 0.00% | – |
| Q1 2022 | $2,845,000 | -22.7% | 987,942 | -18.1% | 0.00% | – |
| Q4 2021 | $3,680,000 | -43.3% | 1,206,352 | +25.2% | 0.00% | – |
| Q3 2021 | $6,493,000 | -57.4% | 963,323 | -1.9% | 0.00% | – |
| Q2 2021 | $15,225,000 | +731.5% | 982,269 | +267.0% | 0.00% | – |
| Q1 2021 | $1,831,000 | – | 267,664 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crumly & Associates Inc. | 32,163 | $93,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 20,075 | $58,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 28,260 | $81,000 | 0.00% |
| Sigma Planning Corp | 21,400 | $62,000 | 0.00% |
| Compagnie Lombard Odier SCmA | 30,000 | $86,000 | 0.00% |
| Gordian Capital Singapore Pte Ltd | 35,000 | $3,000 | 0.00% |
| Welch Group, LLC | 10,000 | $29,000 | 0.00% |
| Renaissance Technologies | 186,300 | $537,000 | 0.00% |
| BRIGHTON JONES LLC | 11,012 | $32,000 | 0.00% |
| Capital Advisors, Ltd. LLC | 24 | $0 | 0.00% |